Phosphoproteomic Profile of Children With Down Syndrome

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

April 16, 2025

Study Completion Date

April 16, 2025

Conditions
Down Syndrome
Interventions
BIOLOGICAL

Blood sample

Recovery of plasma from the bottom of a blood collection tube.

Trial Locations (9)

Unknown

CHRU de Brest, Brest

CHU Grenoble, Grenoble

Medilab, La Châtaigneraie

Hospices Civils de Lyon, Lyon

Medilab, Niort

Institut Jérôme Lejeune, Paris

Medilab, Parthenay

CHU Rennes, Rennes

CHU Saint-Etienne, Saint-Etienne

Sponsors
All Listed Sponsors
collaborator

Proteas Bioanalytics

UNKNOWN

collaborator

Göteborg University

OTHER

lead

Perha Pharmaceuticals

INDUSTRY

NCT06279208 - Phosphoproteomic Profile of Children With Down Syndrome | Biotech Hunter | Biotech Hunter